ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,837,000 | -21.6% | 10,672 | -42.8% | 1.25% | -10.8% |
Q2 2021 | $2,343,000 | -7.5% | 18,672 | 0.0% | 1.40% | -6.7% |
Q1 2021 | $2,532,000 | +6.0% | 18,672 | 0.0% | 1.50% | +9.2% |
Q4 2020 | $2,389,000 | -43.1% | 18,672 | -50.0% | 1.38% | -2.0% |
Q3 2020 | $4,202,000 | +136.2% | 37,344 | +100.0% | 1.40% | +30.6% |
Q2 2020 | $1,779,000 | +6.0% | 18,672 | 0.0% | 1.08% | -27.8% |
Q1 2020 | $1,678,000 | +69.5% | 18,672 | 0.0% | 1.49% | +106.7% |
Q4 2019 | $990,000 | +34.1% | 18,672 | 0.0% | 0.72% | +46.3% |
Q3 2019 | $738,000 | -3.8% | 18,672 | 0.0% | 0.49% | +5.6% |
Q2 2019 | $767,000 | -11.8% | 18,672 | 0.0% | 0.47% | -14.5% |
Q1 2019 | $870,000 | +7.0% | 18,672 | 0.0% | 0.54% | -29.1% |
Q4 2018 | $813,000 | +18.3% | 18,672 | +55.6% | 0.77% | +73.6% |
Q3 2018 | $687,000 | +18.0% | 12,000 | 0.0% | 0.44% | +11.9% |
Q2 2018 | $582,000 | -40.5% | 12,000 | -52.0% | 0.40% | -38.5% |
Q1 2018 | $978,000 | -7.8% | 25,000 | 0.0% | 0.64% | +3.5% |
Q4 2017 | $1,061,000 | +13.7% | 25,000 | 0.0% | 0.62% | +29.0% |
Q3 2017 | $933,000 | +104.6% | 25,000 | +66.7% | 0.48% | +100.0% |
Q2 2017 | $456,000 | – | 15,000 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |